ASTRAZENECA A/S: Financial statements 2025
CVR: 55742928
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
ASTRAZENECA A/S (CVR 55742928) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 630,320,000 and a net result of DKK 24,203,000 compared with DKK 6,241,000 the year before. That is an increase of 32.7% compared with the year before. The profit margin was 3.8%. Equity in the 2025 report amounted to DKK 226,831,000. The solvency ratio was 69.2%. The company had 124 employees in the financial year.
- Revenue
- DKK 630,320,000
- Gross Profit
- DKK 186,256,000
- Profit/Loss
- DKK 24,203,000
- Equity
- DKK 226,831,000
- Total Assets
- DKK 327,562,000
- Employees
- 124
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 630.3 mio. | 186.3 mio. | 24.2 mio. | 226.8 mio. | 124 |
| 2024 | 475.1 mio. | 188.7 mio. | 6.2 mio. | 202.6 mio. | 126 |
| 2023 | 391.1 mio. | 168.5 mio. | 16.2 mio. | 196.4 mio. | 110 |
| 2022 | 395.5 mio. | 137.3 mio. | 11.8 mio. | 180.2 mio. | 89 |
| 2021 | 259.6 mio. | 116.4 mio. | 6.5 mio. | 168.4 mio. | 78 |
Official annual report
How creditworthy is ASTRAZENECA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
ASTRAZENECA A/S has won the tender "Amgros 2026 1.1066.a" issued by Amgros I/S worth 26,000,000 DKK.
ASTRAZENECA A/S has won the tender "Rammeaftale om køb af Truqap (capivasertib)" issued by Amgros I/S worth 44,200,000 DKK.
As of October 30, 2025, Kurt Hungeberg has left the board of directors of ASTRAZENECA A/S.
ASTRAZENECA A/S has won the tender "Amgros 2026 1.364.a" issued by Amgros I/S worth 70,900,000 DKK.
ASTRAZENECA A/S has won the tender "Amgros 2026 1.1475.a" issued by Amgros I/S worth 863,100,000 DKK.
ASTRAZENECA A/S has won the tender "Amgros 2026 1.165.a" issued by Amgros I/S worth 1,566,600,000 DKK.
ASTRAZENECA A/S has published its annual report for 2024. Revenue came to DKK 475,073,000, and the net result was DKK 6,241,000.
As of June 30, 2025, Charlotte Ivang Ladefoged has joined the board of directors of ASTRAZENECA A/S.
About ASTRAZENECA A/S
ASTRAZENECA A/S is a Danish company of the type Aktieselskab based in København V, founded in 1943. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ASTRA DANMARK A/S and ASTRA-GRUPPEN A/S. The management consists of Christof Josef Bischoff. The board consists of Emelie Karin Susanne Antoni (chair), Charlotte Ivang Ladefoged, Christof Josef Bischoff and Erik Jesper Bergkvist. The company is owned by AstraZeneca Continent BV and AstraZeneca AB. The company has 122 employees (2026). In 2025, the company reported revenue of DKK 630,320,000 and a net result of DKK 24,203,000 compared with DKK 6,241,000 the year before. Equity in the 2025 report amounted to DKK 226,831,000.